Immunosuppressive enzymes in the tumor microenvironment

Area of Science:

• Immunology
• Metabolic pathways
• Cancer biology

Background:

• T lymphocytes undergo metabolic alterations upon antigen encounter.
• Tumors engage in metabolic competition with anti-tumor T lymphocytes.
• Immunosuppressive enzymes contribute to a metabolic environment that impairs T cell function.

Purpose of the Study:

• To describe immunosuppressive enzymes involved in tumor-T cell metabolic competition.
• To highlight the role of these enzymes in creating an immunosuppressive microenvironment.
• To present ongoing clinical trials targeting these enzymes for cancer treatment.

Main Methods:

• Review of literature on immunosuppressive enzymes in cancer immunology.
• Description of enzyme classes: amino acid-catabolizing and ATP-degrading ectoenzymes.
• Summary of clinical trials investigating enzyme inhibitors.

Main Results:

• Two classes of immunosuppressive enzymes are identified: those degrading tryptophan, arginine, and phenylalanine, and ectoenzymes producing adenosine.
• These enzymes modify nutrient availability and generate toxic catabolites.
• Targeting these enzymes is being explored in clinical trials.

Conclusions:

• Immunosuppressive enzymes secreted by tumors and the microenvironment are key players in immune evasion.
• Inhibition of these enzymes represents a potential therapeutic strategy to restore anti-tumor T cell activity.
• Clinical trials are actively investigating the efficacy of blocking these enzymes in cancer therapy.